Siliq
- Product NDC
- 0187-0004
- 11-digit product format
- 001870004
- Labeler code
- 0187
- Product ID
- 0187-0004_3031adba-5697-4172-8575-9a1d5d7fc04c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Brodalumab
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Bausch Health US LLC
- Application
- BLA761032
- Marketing category
- BLA
- Marketing start
- 2017-02-15
- Substance
- BRODALUMAB
- Active strength
- 210 mg/1
- Pharmacologic classes
- Antibodies, Monoclonal [CS], Interleukin 17 Receptor A Antagonists [MoA], Interleukin-17 Receptor A Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Siliq
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BRODALUMAB | 210 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6ZA31Y954Z |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0187-0004 | SILIQ (BRODALUMAB) INJECTION [BAUSCH HEALTH US LLC] | 17 | Current NDC, Legacy NDC, 4 package rows | 20241109_1a550c33-456a-4833-814e-8591aea7c688.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0187-0004-00 | 00187000400 | 1 in 1 SYRINGE | | | | | | Historical |
| 0187-0004-02 | 00187000402 | 2 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYRINGE (0187-0004-00) | 2 syringe | 2017-02-15 | 0000-00-00 | No | No | Current |
| 0187-0004-03 | 00187000403 | 2 in 1 CARTON | | | | | | Historical |
| 0187-0004-04 | 00187000404 | 1 in 1 SYRINGE | | | | | | Historical |